eDevice, the world leader in connectivity solutions for the health industry, has just been rewarded for its exceptional results and innovative strategy, which include boasting a three-digit growth figure for two years and 2016 turnover estimated at €50 million.
eDevice is gaining recognition and has won the ‘Grand Prix des Entreprises de Croissance 2016’ for high-growth companies in the ‘Health, Pharma and Medtech’ category.
Precursor to the Internet of Things
Marc Berrebi and Stéphane Schinazi, co-founders of eDevice, a Bordeaux start-up created in 1999, collected the prize on the 29 June 2016 in Paris, accompanied by their team.
Marc Berrebi said: “In 2000, eDevice invented the Internet of Things, but it was ahead of its time. Now we are reaping the rewards of our investment and we possess the perfect technological tool to allow doctors to monitor their patients remotely.”
Within just a few years, eDevice has become the world leader in connectivity solutions for the health industry and generates 99.8% of its turnover abroad. The business connects several thousand patients around the world and so helps people suffering with chronic illnesses to have a better standard of living.
Exceptional growth rates
eDevice is growing rapidly thanks to its technological innovations which allow patients to improve their quality of life.
Their modular solution covers all needs relating to connected health: designing and creating communication devices, providing access to mobile networks (MVNO), storing medical information, management and monitoring tools and applications for displaying and analyzing health data. This comprehensive solution, associated with great flexibility, competitive prices and telecom and medical certifications around the world, allowed eDevice to reach the exceptional growth rate of 160% in 2015 and an estimate of 155% in 2016.
These impressive results translated into hiring 6 new permanent employees in the first quarter of 2016 to reinforce the sales and administration team.
eDevice will be keeping up their growth strategy, firstly by expanding their offering in order to become the key partner for major international Medtech players and secondly by continuing their internationalization, notably into Asia through a strategic partnership with a major market player.
(Source: Press release 04/07/2016)